Hostname: page-component-74656f9884-rngvg Total loading time: 0 Render date: 2026-11-05T09:11:21.047Z Has data issue: false hasContentIssue false

Iptriazopyrid undergoes limited metabolism in a mesotrione-resistant Palmer amaranth (Amaranthus palmeri) accession

Published online by Cambridge University Press:  30 July 2026

Susee Sudhakar*
Affiliation:
Crop, Soil, and Environmental Sciences, University of Arkansas Division of Agriculture , Fayetteville, USA
Jason K. Norsworthy
Affiliation:
Crop, Soil, and Environmental Sciences, University of Arkansas Division of Agriculture , Fayetteville, USA
Waidath Bio-Sawe
Affiliation:
Crop, Soil, and Environmental Sciences, University of Arkansas Division of Agriculture , Fayetteville, USA
Amar Godar
Affiliation:
Crop, Soil, and Environmental Sciences, University of Arkansas Division of Agriculture , Fayetteville, USA
*
Corresponding author: Susee Sudhakar; Email: ssudhakar@uada.edu
Rights & Permissions [Opens in a new window]

Abstract

Palmer amaranth (Amaranthus palmeri S. Watson) is among the most problematic weeds in U.S. rowcrop systems. In furrow-irrigated rice (Oryza sativa L.) (FIR), which is typically produced within soybean [Glycine max (L.) Merr.]- and corn (Zea mays L.)-dominated landscapes in the U.S. Midsouth that contain preexisting resistant seedbanks, the absence of continuous flooding allows season-long weed emergence, while effective postemergence control options remain limited. Iptriazopyrid, a novel azole carboxamide 4hydroxyphenylpyruvate dioxygenase (HPPD)-inhibitor under development for use in rice, possesses a chemical structure distinct from triketones such as mesotrione. Whether this structurally different HPPD-inhibitor endows altered susceptibility to metabolic resistance mechanisms in A. palmeri remains unknown. Therefore, the objectives were to evaluate the postemergence efficacy of iptriazopyrid and to compare its parent compound depletion with mesotrione in known mesotrione resistant (MSR2) and mesotrione-susceptible A. palmeri accessions (1986 and/or 21–115). Dose–response experiments showed that iptriazopyrid maintained consistent efficacy across accessions, with no significant differences among estimated response parameters. In contrast, mesotrione required 2.83- to 9.21-fold higher rates in MSR2 to achieve responses comparable to those observed in the susceptible 1986 accession. Quantification of parent compound over time revealed limited depletion of iptriazopyrid across accessions, with >95% of the parent compound remaining up to 12 h after treatment in all three accessions and approximately 75% remaining at 24 h in MSR2. Conversely, mesotrione underwent rapid metabolism in MSR2, declining to 18% of the parent compound by 8 h and to <6% by 24 h, indicating that resistance mechanisms conferring reduced sensitivity to mesotrione in MSR2 do not similarly compromise iptriazopyrid. Therefore, iptriazopyrid may provide an effective postemergence option for managing A. palmeri in FIR, including mesotrione-resistant populations, and may help diversify herbicide programs and reduce selection for metabolic resistance in U.S. Midsouth cropping systems.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Weed Science Society of America
Figure 0

Table 1. Dose–response estimates for plant mortality at 4 wk after treatment with mesotrione and iptriazopyrid in Amaranthus palmeri accessions 1986 and MSR2aTable 1 long description.

Figure 1

Figure 1. Dose–response curves for percent control of Amaranthus palmeri accessions in response to mesotrione (A) and iptriazopyrid (B). Points represent treatment means with 95% confidence intervals. Curves were fit using a four-parameter log-logistic model with the lower and upper asymptotes fixed at 0% and 100%, respectively. Diamonds indicate absolute LD50 estimates with 95% confidence intervals. The dashed vertical line denotes normal current use or anticipated use rate.

Figure 2

Table 2. Dose–response estimates for growth reduction at 4 wk after treatment with mesotrione and iptriazopyrid in Amaranthus palmeri accessions 1986 and MSR2aTable 2 long description.

Figure 3

Table 3. Dose–response estimates for visible injury at 4 wk after treatment with mesotrione and iptriazopyrid in Amaranthus palmeri accessions 1986 and MSR2aTable 3 long description.

Figure 4

Figure 2. Time course of parent compound (% remaining) for mesotrione (A) and iptriazopyrid (B) in Amaranthus palmeri accessions. Accessions 1986 and 21–115 are known mesotrione susceptible, and MSR2 is resistant to mesotrione. Data represent mean ± 1 SE. Similar letters above SE bar indicate no difference at α = 0.05.

Figure 5

Figure 3. Figure 3 long description.Representative high-performance liquid chromatography chromatographs showing mesotrione detection and metabolism in Amaranthus palmeri accessions 1986 (susceptible), 21–115 (susceptible), and MSR2 (resistant), under nontreated (NT) conditions, 8 h after treatment (8 HAT), and 24 HAT. The retention time of mesotrione is approximately 9.75 min (indicated by wedge). The MSR2 accession showed reduced mesotrione peak intensity over time compared with the two susceptible accessions, suggesting enhanced metabolism, whereas 1986 and 21–115 retained a more pronounced mesotrione peak at corresponding time points.

Figure 6

Figure 4. Representative high-performance liquid chromatography chromatographs showing iptriazopyrid detection in Amaranthus palmeri accessions 1986 (mesotrione-susceptible), 21–115 (mesotrione-susceptible), and MSR2 (mesotrione-resistant), under nontreated (NT) conditions and 24 h after treatment (HAT). The retention time of iptriazopyrid is approximately 9.51 min (indicated by wedge). Comparable peak intensities across accessions at 24 HAT suggest limited or no differential metabolism of iptriazopyrid among mesotrione-resistant and mesotrione-susceptible accessions examined.